Zila, Nina http://orcid.org/0000-0003-1193-1014
Hoeller, Christoph http://orcid.org/0000-0003-1192-0227
Paulitschke, Verena http://orcid.org/0000-0003-0212-9476
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 27 January 2021
Accepted: 1 March 2021
First Online: 31 March 2021
Conflict of interest
: C. Hoeller declares the following: Speaker for Amgen, BMS, MSD, Novartis and Roche. Consultancy for Amgen, Astra Zeneca, BMS, Inzyte, MSD, Novartis, Pierre Fabre and Roche. Research support from Amgen. N. Zila and V. Paulitschke declare that they have no competing interests.